Recommendations and exploration of diagnosis and treatment of critical and refractory immune checkpoint inhibitor‐associated adverse events

The application of immune checkpoint inhibitors (ICIs) has rewritten many malignant tumor treatment strategies and become another milestone in tumor treatment. This article summarizes the latest domestic and international guidelines and consensus regarding the diagnosis and treatment of grade 3–4 im...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Peng, Wang, Hanping, Si, Xiaoyan, Guo, Xiaoxiao, Li, Yue, Zhou, Jiaixin, Duan, Lian, Zhang, Li, Wang, Mengzhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Invited Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396364/
http://dx.doi.org/10.1111/1759-7714.13553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396364/
http://dx.doi.org/10.1111/1759-7714.13553

Ejemplares similares